This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, M. B.
Right arrow Articles by Gilligan, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M. B.
Right arrow Articles by Gilligan, P. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2004, p. 855-857, Vol. 42, No. 2
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.2.855-857.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Prevalence of Vancomycin-Resistant Enterococcus in Prenatal Screening Cultures

Melissa B. Miller,1 Sonia L. Allen,1 Mary Ellen Mangum,1 Anastassia Doutova,1 and Peter H. Gilligan1,2*

Clinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals,1 Departments of Pathology and Laboratory Medicine and Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina2

Received 11 September 2003/ Returned for modification 8 October 2003/ Accepted 13 November 2003

Recommendations for the perinatal treatment of women colonized with Streptococcus agalactiae include vancomycin prophylaxis for those with severe penicillin allergies and antibiotic-resistant organisms. Because of potential postpartum infections due to vancomycin-resistant enterococci (VRE) and the possible spread of vancomycin resistance, the prevalence of VRE in prenatal screening cultures was determined.


* Corresponding author. Mailing address: Clinical Microbiology-Immunology Laboratories, UNC Hospitals, 101 Manning Dr., East Wing 1035, Chapel Hill, NC 27514. Phone: (919) 966-6313. Fax: (919) 966-0486. E-mail: pgilliga{at}unch.unc.edu.


Journal of Clinical Microbiology, February 2004, p. 855-857, Vol. 42, No. 2
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.2.855-857.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.